For the entire fiscal year, also ended March 31, revenues reached $137.6 billion, up 12.6 percent from last year’s revenue of $122.1 billion.
“I am pleased with our fourth-quarter results led by solid execution across the distribution solutions and technology solutions segments,” said John H. Hammergren, chairman and CEO of McKesson, in a news release. “These results were driven primarily by outstanding performance in the distribution solutions segment and disciplined working capital management across the company.”
McKesson’s results were not significantly affected by its takeover of former rival Celesio. Additional income from Celesio was mostly offset by costs associated with the acquisition, though McKesson officials believe Celesio will help revenues grow even more in coming quarters.
“During the fourth quarter, we secured the acquisition of Celesio which marks an important step for McKesson as we expand to serve our customers and manufacturing partners with global scale,” said Mr. Hammergran in the news release.
More Articles on McKesson:
7 Recent Go-Lives
NewYork-Presbyterian, McKesson, Other Health IT Leaders Named to InformationWeek’s Elite 100
15 Recent Stories on the Health IT Market
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
